Skip to content
Search

Latest Stories

RPS: Prescription rules need to be changed urgently

Cutting the red tape that blocks pharmacists to alter the HRT prescription could ‘quickly fix’ the problem of women unable to access their HRT medicines, the Royal Pharmaceutical Society (RPS) told Daily Mail.

RPS has suggested that allowing pharmacists to prescribe alternative HRT treatment amid nationwide shortage of HRT medicine could help the women who are struggling to access these medicines.


Thorrun Govind, chair of the English Pharmacy Board, told MailOnline ‘changes in prescription rules need to be changed urgently.’

She added, 'For the pharmacists on the ground, they need the ability to get rid of this bureaucracy. When you think about it — who's best able to offer an alternative — that tends to be the pharmacist.'

MailOnline quoted Professor Claire Anderson, president of the Royal Pharmaceutical Society, as said, 'We welcome the Health Secretary meeting with key suppliers and manufacturers to find solutions to the current shortages. But cutting the red tape holding pharmacists back could provide a 'quick fix' that would allow 'women to access their HRT medicines more speedily'.

Claire said, 'At present, women have to go back to their GP to get a minor amendment made. Enabling pharmacists to alter prescriptions would also be far more efficient for the NHS.'

According to MailOnline report, London-based firm Theramex, which makes similar hormone replacement therapy gels, said it warned the Department of Health about the impending crisis last October.

Last week, Sajid Javid appointed Madelaine McTernan as the new HRT tsar to spearhead efforts to deal with shortages of the medicine. DHSC also has issued SSPs on three HRT medicines to limit dispensing supply to three months. To ensure women across the UK will be able to more reliably access HRT products SSPs has been issued on the supply of Oestrogel, Ovestin cream and Premique Low Dose.

DHSC stated: “Women who have a prescription for more than three months but are only able to access three months’ supply will not have to pay an additional prescription charge.”

On May 5, Sajid Javid and Madelaine McTernan, head of the HRT supply taskforce, met the drug manufacturers and representatives from community pharmacies discuss on ways to resolve the shortage of HRT medicines.

In the meeting, manufacturers outlined the steps they’re taking to boost supply, and pharmacists shared their experiences on the frontline, as well as sharing their thoughts on wider solutions including improved communications.

Aspen Pharmacare, Besins-Healthcare, Gedeon Richter, Novartis, Novo Nordisk, Orion, Pfizer, Theramex, Viatris, and representatives from community pharmacies were part of the meeting.

As the government confirmed its intention to work with industry to do what is necessary to fix the HRT supply issue, Javid said he wanted to understand the issues facing suppliers and what can be done to address them.

'Delaying this move will frustrate many who already pay for monthly HRT prescriptions and will further drive health inequalities already experienced by women across the country,’ Thorrun told MailOnline.

She added HRT prescriptions are 'essential' but also 'a financial drain during a cost-of-living crisis' as she called for prescription charges for such treatment to be scrapped entirely in England.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less